Pediatrix Medical Group Statistics
Pediatrix Medical Group (PDC) Stock Statistics & Valuation Metrics
Total Valuation
Pediatrix Medical Group has a market cap or net worth of CHF 2.06B. The enterprise value is CHF 2.24B.
- Market Cap
- CHF 2.06B
- Enterprise Value
- CHF 2.24B
Share Statistics
Pediatrix Medical Group has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- ―
- Owned by Insiders
- 1.62%
- Owned by Institutions
- 81.07%
Financial Efficiency
Pediatrix Medical Group’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 9.67%.
- Return on Equity (ROE)
- 0.19
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 9.67%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 447.16K
- Profits Per Employee
- 38.64K
- Employee Count
- 4,280
- Asset Turnover
- 0.85
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Pediatrix Medical Group is 16.82. Pediatrix Medical Group’s PEG ratio is -15.89.
- PE Ratio
- 16.82
- PS Ratio
- 1.25
- PB Ratio
- 2.86
- Price to FCF
- 11.70
- Price to Operating Cash Flow
- 10.70
- PEG Ratio
- -15.89
Income Statement
In the last 12 months, Pediatrix Medical Group had revenue of 1.91B and earned 165.39M in profits. Earnings per share was 1.94.
- Revenue
- 1.91B
- Gross Profit
- 471.88M
- Operating Income
- 231.09M
- Pretax Income
- 216.43M
- Net Income
- 165.39M
- EBITDA
- 274.22M
- Earnings Per Share (EPS)
- 1.94
Cash Flow
In the last 12 months, operating cash flow was 227.23M and capital expenditures -17.29M, giving a free cash flow of 209.94M billion.
- Operating Cash Flow
- 227.23M
- Free Cash Flow
- 209.94M
- Free Cash Flow per Share
- 2.72
Dividends & Yields
Pediatrix Medical Group pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.54%
- Earnings Yield
- 6.17%
Important Dates
Pediatrix Medical Group upcoming earnings date is Feb 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Pediatrix Medical Group as a current ratio of 1.66, with Debt / Equity ratio of 76.26%
- Current Ratio
- 1.66
- Quick Ratio
- 1.66
- Debt to Market Cap
- 0.35
- Net Debt to EBITDA
- 1.04
- Interest Coverage Ratio
- 6.43
Taxes
In the past 12 months, Pediatrix Medical Group has paid 51.04M in taxes.
- Income Tax
- 51.04M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Pediatrix Medical Group EV to EBITDA ratio is 11.03, with an EV/FCF ratio of 13.14.
- EV to Sales
- 1.41
- EV to EBITDA
- 11.03
- EV to Free Cash Flow
- 13.14
- EV to Operating Cash Flow
- 12.14
Balance Sheet
Pediatrix Medical Group has CHF 425.84M in cash and marketable securities with CHF 612.00M in debt, giving a net cash position of -CHF 186.16M billion.
- Cash & Marketable Securities
- CHF 425.84M
- Total Debt
- CHF 612.00M
- Net Cash
- -CHF 186.16M
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- -CHF 5.59
Margins
Gross margin is 25.83%, with operating margin of 11.40%, and net profit margin of 7.66%.
- Gross Margin
- 25.83%
- Operating Margin
- 11.40%
- Pretax Margin
- 10.38%
- Net Profit Margin
- 7.66%
- EBITDA Margin
- 12.76%
- EBIT Margin
- 11.55%
Analyst Forecast
The average price target for Pediatrix Medical Group is CHF 23.66, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
- Price Target
- CHF 23.66
- Price Target Upside
- ―
- Analyst Consensus
- Moderate Sell
- Analyst Count
- 3
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 5
- AI Score
- ―
